Dapoxetine Early 2006 Launch Expectations Premature, J&J Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Johnson & Johnson does not expect FDA approval of its premature ejaculation therapy dapoxetine in time for an early 2006 launch